Evidence map›Paper›PMID 42423176›Full record

ArticleAging cell2026

Traditional Disease Risk Factors Outperform Epigenetic Clocks as Predictors of Non-Communicable Disease Morbidity in a Middle-Aged Cohort.

Daria Kostiniuk, Flóra Székely, Leo-Pekka Lyytikäinen, Jo Ciantar, Sonja Rajić, Pashupati P Mishra, Terho Lehtimäki, Katja Pahkala, Suvi Rovio, Juha Mykkänen and 3 more

Abstract read
In one paragraph

Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daria KostiniukMolecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Flóra SzékelyMolecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Leo-Pekka LyytikäinenDepartment of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Jo CiantarMolecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Sonja RajićMolecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Pashupati P MishraDepartment of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Terho LehtimäkiDepartment of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Katja PahkalaResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Suvi RovioResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Juha MykkänenResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Olli RaitakariResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
Emma RaitoharjuMolecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Saara MarttilaMolecular Epidemiology (MOLE), Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Funding

Academy of Finland 117797Academy of Finland 121584Academy of Finland 124282Academy of Finland 126925Academy of Finland 129378Academy of Finland 134309Academy of Finland 141071Academy of Finland 286284Academy of Finland 322098Academy of Finland 330809Academy of Finland 338395Academy of Finland 349708Academy of Finland 356405Cancer Foundation FinlandCompetitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University HospitalsCVDLink 101137278Diabetes Research Foundation of the Finnish Diabetes AssociationEU Horizon 2020 755320EU Horizon 2020 848146European Research Council 742927Finnish Foundation for Cardiovascular ResearchFinnish Society of Clinical ChemistryJuho Vainio FoundationPaavo Nurmi FoundationPäivikki and Sakari Sohlberg FoundationpBETTER4U_EU 101080117Pirkanmaa Regional Fund of the Finnish Cultural FoundationSigne and Ane Gyllenberg FoundationSigrid Juselius FoundationSocial Insurance Institution of FinlandTampere Tuberculosis FoundationTampere University Hospital Supporting FoundationThe Emil Aaltonen Foundationthe Finnish Cultural FoundationThe Jane and Aatos Erkko FoundationThe Paulo FoundationYrjö Jahnsson Foundation
6 · The paper itself

Abstract

DNA methylation-based epigenetic clocks have been highlighted as promising biomarkers of ageing, and they have been shown to robustly predict morbidity and mortality. However, current literature is lacking a formal analysis of the increased prediction accuracy, or the added value, of the epigenetic clocks over traditional risk factors, such as body composition, smoking, or alcohol consumption, in predicting common chronic diseases. Here, we have compared the most commonly used epigenetic clocks and traditional risk factors as predictors of incidence of ageing-associated non-communicable chronic disease in a 7-to-9-year follow-up in a middle-aged population cohort (n = 1108, aged 34 to 49 years at baseline). In our cohort, a statistical model consisting of a combination of traditional risk factors (age, sex, smoking, alcohol consumption, WHR, BMI) outperforms any model including an epigenetic clock. The added value of epigenetic clock measurements over simple and affordable traditional risk factors should be clearly established if epigenetic clocks are to be used in clinical settings or as tools of personal health monitoring.

Indexed as

AgingEpigenesis, GeneticNoncommunicable DiseasesAdultCohort StudiesDNA MethylationFemaleHumansMaleMiddle AgedMorbidityRisk Factorsageingbiological agebiomarker of ageepigenetic ageepigenetic clock

Identifiers

PMID42423176
PMCPMC13347623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.